We detected the phosphorylation of p38 MAPK and JNK proteins in PC-3 and DU-145 cells and found the expressions were dose dependence, so it meant that the CTN also could active p38 MAPK and JNK in prostate cancer cells (Supplementary Figure 1). Here, MAPK8 is linked to prostate carcinoma.